| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.786 | 0.017 | 0.804 | Antiinflammatory | 0.804 0.015 CID_154699984 | CID_154699984 | |
| 0.668 | 0.004 | 0.668 | Non-steroidal antiinflammatory agent | 0.524 0.005 CID_154699984 | ||
| 0.595 | 0.004 | 0.595 | Cyclooxygenase 1 inhibitor | 0.519 0.005 CID_154699984 | ||
| 0.586 | 0.02 | 0.586 | Cholesterol antagonist | 0.414 0.047 CID_154699984 | ||
| 0.501 | 0.005 | 0.501 | Amyloid beta precursor protein antagonist | 0.472 0.005 CID_154699984 | ||
| 0.488 | 0.02 | 0.488 | Lipoxygenase inhibitor | 0.411 0.035 CID_154699984 | ||
| 0.461 | 0.005 | 0.461 | Cyclooxygenase inhibitor | 0.455 0.005 CID_154699984 | ||
| 0.387 | 0.008 | 0.387 | Interleukin 6 antagonist | 0.349 0.01 CID_154699984 | ||
| 0.391 | 0.02 | 0.397 | Sodium/bile acid cotransporter inhibitor | 0.397 0.018 CID_154699984 | CID_154699984 | |
| 0.424 | 0.055 | 0.424 | Immunosuppressant | 0.339 0.092 CID_154699984 | ||
| 0.436 | 0.07 | 0.436 | Analgesic | |||
| 0.385 | 0.028 | 0.385 | Hypolipemic | 0.264 0.061 CID_154699984 | ||
| 0.368 | 0.021 | 0.368 | Anesthetic general | 0.291 0.035 CID_154699984 | ||
| 0.334 | 0.01 | 0.334 | Cyclooxygenase 2 inhibitor | 0.281 0.015 CID_154699984 | ||
| 0.364 | 0.041 | 0.452 | Calcium channel activator | 0.452 0.011 CID_154699984 | CID_154699984 | |
| 0.366 | 0.072 | 0.366 | Transcription factor NF kappa B inhibitor | 0.252 0.126 CID_154699984 | ||
| 0.333 | 0.041 | 0.333 | Interleukin antagonist | 0.238 0.066 CID_154699984 | ||
| 0.323 | 0.055 | 0.323 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.299 | 0.033 | 0.299 | Gastrin inhibitor | 0.285 0.045 CID_154699984 | ||
| 0.319 | 0.065 | 0.319 | Nootropic | |||
| 0.365 | 0.112 | 0.365 | Cyclophilin D inhibitor | |||
| 0.32 | 0.076 | 0.54 | Antithrombotic | 0.54 0.024 CID_154699984 | CID_154699984 | |
| 0.242 | 0.004 | 0.242 | Sphingosine 1-phosphate receptor 2 antagonist | 0.141 0.055 CID_154699984 | ||
| 0.236 | 0.005 | 0.236 | CYP2A6 inhibitor | |||
| 0.25 | 0.019 | 0.253 | Interleukin 1 antagonist | 0.253 0.018 CID_154699984 | CID_154699984 | |
| 0.242 | 0.018 | 0.242 | Cell wall synthesis inhibitor | 0.149 0.067 CID_154699984 | ||
| 0.227 | 0.016 | 0.227 | Antibacterial (Helicobacter pylori) | |||
| 0.267 | 0.067 | 0.267 | Hypoglycemic | 0.191 0.121 CID_154699984 | ||
| 0.256 | 0.057 | 0.256 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.212 | 0.022 | 0.229 | Arachidonic acid antagonist | 0.229 0.012 CID_154699984 | CID_154699984 | |
| 0.25 | 0.061 | 0.25 | Pyruvate kinase inhibitor | |||
| 0.228 | 0.04 | 0.228 | Thrombolytic | 0.213 0.046 CID_154699984 | ||
| 0.259 | 0.079 | 0.286 | Aldehyde oxidase inhibitor | 0.286 0.07 CID_154699984 | CID_154699984 | |
| 0.193 | 0.015 | 0.206 | Mucolytic | 0.206 0.012 CID_154699984 | CID_154699984 | |
| 0.25 | 0.075 | 0.25 | Superoxide dismutase inhibitor | 0.238 0.083 CID_154699984 | ||
| 0.206 | 0.032 | 0.206 | ATPase inhibitor | 0.155 0.094 CID_154699984 | ||
| 0.201 | 0.035 | 0.201 | Insulin secretagoues | 0.157 0.068 CID_154699984 | ||
| 0.211 | 0.046 | 0.211 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.291 | 0.129 | 0.291 | Histamine release inhibitor | 0.256 0.151 CID_154699984 | ||
| 0.17 | 0.008 | 0.17 | Prostaglandin EP2 antagonist | |||
| 0.164 | 0.005 | 0.164 | Peroxisome proliferator-activated receptor gamma antagonist | 0.096 0.018 CID_154699984 | ||
| 0.195 | 0.036 | 0.195 | Catenin beta inhibitor | |||
| 0.172 | 0.018 | 0.172 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.161 | 0.009 | 0.161 | Prostaglandin antagonist | |||
| 0.158 | 0.007 | 0.158 | Alpha 2d adrenoreceptor antagonist | |||
| 0.175 | 0.029 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.06 CID_154699984 | ||
| 0.184 | 0.039 | 0.194 | Alpha-N-acetylglucosaminidase inhibitor | 0.194 0.036 CID_154699984 | CID_154699984 | |
| 0.174 | 0.031 | 0.208 | Cyclooxygenase 3 inhibitor | 0.208 0.016 CID_154699984 | CID_154699984 | |
| 0.302 | 0.163 | 0.302 | 5 Hydroxytryptamine release inhibitor | |||
| 0.167 | 0.029 | 0.19 | Expectorant | 0.19 0.022 CID_154699984 | CID_154699984 | |
| 0.267 | 0.137 | 0.267 | Calpain 2 inhibitor | |||
| 0.165 | 0.038 | 0.165 | Cell adhesion inhibitor | |||
| 0.198 | 0.073 | 0.198 | Histone acetyltransferase inhibitor | |||
| 0.175 | 0.053 | 0.175 | Protein kinase stimulant | 0.131 0.082 CID_154699984 | ||
| 0.15 | 0.028 | 0.15 | Mediator release inhibitor | |||
| 0.118 | 0.004 | 0.118 | Urate transporter 1 inhibitor | |||
| 0.152 | 0.042 | 0.152 | Heat shock protein 70 antagonist | |||
| 0.117 | 0.009 | 0.117 | Peroxisome proliferator-activated receptor alpha agonist | 0.069 0.022 CID_154699984 | ||
| 0.13 | 0.023 | 0.13 | Estrogen receptor beta antagonist | 0.113 0.042 CID_154699984 | ||
| 0.15 | 0.044 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.031 CID_154699984 | CID_154699984 | |
| 0.189 | 0.085 | 0.189 | Insulin sensitizer | |||
| 0.118 | 0.014 | 0.118 | NMDA receptor agonist | 0.065 0.041 CID_154699984 | ||
| 0.144 | 0.04 | 0.144 | Ferrochelatase inhibitor | 0.14 0.042 CID_154699984 | ||
| 0.108 | 0.005 | 0.108 | DNA helicase inhibitor | 0.1 0.005 CID_154699984 | ||
| 0.124 | 0.022 | 0.124 | Cell adhesion molecule inhibitor | 0.072 0.066 CID_154699984 | ||
| 0.105 | 0.005 | 0.105 | Retinoid X alpha receptor agonist | 0.087 0.006 CID_154699984 | ||
| 0.12 | 0.019 | 0.12 | Bile acid receptor antagonist | 0.119 0.021 CID_154699984 | ||
| 0.133 | 0.035 | 0.133 | Estrogen antagonist | 0.12 0.055 CID_154699984 | ||
| 0.106 | 0.009 | 0.117 | Glutamate (mGluR6) antagonist | 0.117 0.006 CID_154699984 | CID_154699984 | |
| 0.262 | 0.166 | 0.266 | Antibacterial | 0.266 0.162 CID_154699984 | CID_154699984 | |
| 0.173 | 0.077 | 0.18 | Succinate dehydrogenase inhibitor | 0.18 0.068 CID_154699984 | CID_154699984 | |
| 0.212 | 0.116 | 0.234 | Tyrosine 3 hydroxylase inhibitor | 0.234 0.085 CID_154699984 | CID_154699984 | |
| 0.184 | 0.088 | 0.184 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.139 | 0.044 | 0.139 | Microtubule formation inhibitor | |||
| 0.107 | 0.013 | 0.107 | NMDA receptor glycine site agonist | |||
| 0.128 | 0.035 | 0.128 | Interleukin 2 antagonist | |||
| 0.129 | 0.036 | 0.129 | DOPA decarboxylase inhibitor | |||
| 0.232 | 0.14 | 0.256 | Interleukin 2 agonist | 0.256 0.112 CID_154699984 | CID_154699984 | |
| 0.104 | 0.014 | 0.104 | Prostaglandin E2 antagonist | |||
| 0.133 | 0.044 | 0.133 | 5-Lipoxygenase inhibitor | |||
| 0.094 | 0.006 | 0.094 | CXC chemokine 1 receptor antagonist | 0.079 0.009 CID_154699984 | ||
| 0.116 | 0.029 | 0.116 | Ornithine decarboxylase inhibitor | 0.115 0.03 CID_154699984 | ||
| 0.1 | 0.013 | 0.1 | Transcription factor AP-1 inhibitor | |||
| 0.12 | 0.032 | 0.12 | Triose-phosphate isomerase inhibitor | 0.119 0.033 CID_154699984 | ||
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | 0.088 0.029 CID_154699984 | ||
| 0.093 | 0.006 | 0.093 | Peroxisome proliferator-activated receptor delta agonist | 0.047 0.013 CID_154699984 | ||
| 0.162 | 0.076 | 0.162 | Neurotensin receptor agonist | |||
| 0.117 | 0.033 | 0.117 | ABCA1 expression enhancer | 0.113 0.036 CID_154699984 | ||
| 0.155 | 0.071 | 0.155 | Interferon gamma antagonist | 0.134 0.104 CID_154699984 | ||
| 0.107 | 0.024 | 0.107 | Peroxisome proliferator-activated receptor gamma agonist | 0.091 0.033 CID_154699984 | ||
| 0.127 | 0.048 | 0.127 | Chelator | 0.117 0.056 CID_154699984 | ||
| 0.084 | 0.007 | 0.084 | Retinoid X receptor agonist | 0.071 0.01 CID_154699984 | ||
| 0.099 | 0.022 | 0.099 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.116 | 0.041 | 0.116 | Nitric-oxide synthase inhibitor | |||
| 0.086 | 0.011 | 0.086 | Macrophage elastase inhibitor | 0.039 0.035 CID_154699984 | ||
| 0.134 | 0.059 | 0.134 | Vanilloid 1 agonist | 0.128 0.07 CID_154699984 | ||
| 0.084 | 0.01 | 0.084 | Thromboxane synthase inhibitor | 0.073 0.015 CID_154699984 | ||
| 0.125 | 0.052 | 0.125 | Photosensitizer | |||
| 0.216 | 0.145 | 0.216 | Immunomodulator | |||
| 0.078 | 0.008 | 0.078 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.096 | 0.029 | 0.096 | T cell inhibitor | |||
| 0.078 | 0.012 | 0.078 | Glucose-6-phosphate translocase inhibitor | |||
| 0.162 | 0.097 | 0.233 | Hepatoprotectant | 0.233 0.049 CID_154699984 | CID_154699984 | |
| 0.074 | 0.009 | 0.074 | TRPM8 blocker | |||
| 0.146 | 0.083 | 0.146 | Protein-tyrosine phosphatase inhibitor | |||
| 0.205 | 0.142 | 0.231 | 5 Hydroxytryptamine uptake stimulant | 0.231 0.102 CID_154699984 | CID_154699984 | |
| 0.081 | 0.019 | 0.081 | Thromboxane antagonist | |||
| 0.123 | 0.062 | 0.123 | Cholesterol synthesis inhibitor | 0.1 0.087 CID_154699984 | ||
| 0.066 | 0.004 | 0.07 | Retinoid X receptor antagonist | 0.07 0.004 CID_154699984 | CID_154699984 | |
| 0.187 | 0.126 | 0.205 | Antioxidant | 0.205 0.11 CID_154699984 | CID_154699984 | |
| 0.098 | 0.038 | 0.098 | Inducible nitric-oxide synthase inhibitor | |||
| 0.144 | 0.086 | 0.144 | Hexokinase inhibitor | |||
| 0.155 | 0.098 | 0.18 | Lipocortins synthesis antagonist | 0.18 0.071 CID_154699984 | CID_154699984 | |
| 0.065 | 0.009 | 0.065 | AMPA 4 receptor antagonist | 0.052 0.014 CID_154699984 | ||
| 0.119 | 0.063 | 0.119 | Interleukin 8 antagonist | 0.114 0.07 CID_154699984 | ||
| 0.061 | 0.007 | 0.061 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.056 | 0.004 | 0.06 | Retinoid X alpha receptor antagonist | 0.06 0.004 CID_154699984 | CID_154699984 | |
| 0.088 | 0.037 | 0.088 | Estrogen receptor alpha antagonist | |||
| 0.055 | 0.005 | 0.055 | Integrin alpha1beta1 antagonist | |||
| 0.103 | 0.053 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.074 | 0.025 | 0.079 | Aldose reductase inhibitor | 0.079 0.024 CID_154699984 | CID_154699984 | |
| 0.056 | 0.007 | 0.056 | Prostaglandin EP4 antagonist | |||
| 0.241 | 0.193 | 0.241 | Transcription factor inhibitor | |||
| 0.079 | 0.032 | 0.079 | Neutrophil collagenase inhibitor | |||
| 0.145 | 0.099 | 0.145 | Nitric oxide antagonist | 0.134 0.113 CID_154699984 | ||
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | |||
| 0.103 | 0.06 | 0.103 | Folate antagonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | 0.052 0.019 CID_154699984 | ||
| 0.087 | 0.046 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.042 CID_154699984 | CID_154699984 | |
| 0.065 | 0.025 | 0.065 | Thromboxane A2 antagonist | |||
| 0.057 | 0.018 | 0.057 | Estrogen receptor beta agonist | |||
| 0.066 | 0.027 | 0.066 | Alpha tubulin antagonist | |||
| 0.157 | 0.119 | 0.157 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.182 | 0.145 | 0.182 | Streptokinase A inhibitor | |||
| 0.074 | 0.036 | 0.074 | Leukotriene antagonist | |||
| 0.055 | 0.018 | 0.055 | Geranyltranstransferase inhibitor | 0.04 0.036 CID_154699984 | ||
| 0.079 | 0.042 | 0.079 | Vanilloid 4 agonist | |||
| 0.04 | 0.003 | 0.04 | Retinoid X beta receptor antagonist | 0.034 0.004 CID_154699984 | ||
| 0.101 | 0.065 | 0.125 | GABA C receptor agonist | 0.125 0.046 CID_154699984 | CID_154699984 | |
| 0.046 | 0.011 | 0.046 | Prostaglandin agonist | |||
| 0.198 | 0.164 | 0.198 | Thyroid hormone antagonist | |||
| 0.11 | 0.076 | 0.11 | Topoisomerase II inhibitor | |||
| 0.046 | 0.011 | 0.046 | Free fatty acid receptor 1 antagonist | 0.037 0.019 CID_154699984 | ||
| 0.068 | 0.034 | 0.068 | Protein kinase C iota inhibitor | |||
| 0.086 | 0.054 | 0.086 | Vanilloid agonist | 0.078 0.076 CID_154699984 | ||
| 0.222 | 0.19 | 0.222 | 15-Lipoxygenase inhibitor | |||
| 0.06 | 0.03 | 0.067 | Estrogen agonist | 0.067 0.027 CID_154699984 | CID_154699984 | |
| 0.124 | 0.094 | 0.124 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.035 | 0.005 | 0.035 | Free fatty acid receptor 1 agonist | 0.016 0.014 CID_154699984 | ||
| 0.106 | 0.077 | 0.117 | TRPA1 agonist | 0.117 0.062 CID_154699984 | CID_154699984 | |
| 0.043 | 0.014 | 0.043 | AMPA receptor agonist | 0.035 0.026 CID_154699984 | ||
| 0.084 | 0.055 | 0.084 | Glutathione S-transferase inhibitor | |||
| 0.107 | 0.08 | 0.107 | Caspase 3 inhibitor | |||
| 0.035 | 0.008 | 0.035 | Nicotinic acid receptor 2 antagonist | |||
| 0.035 | 0.009 | 0.035 | Prostaglandin E2 agonist | |||
| 0.093 | 0.067 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.076 | 0.05 | 0.083 | Porphobilinogen synthase inhibitor | 0.083 0.045 CID_154699984 | CID_154699984 | |
| 0.031 | 0.006 | 0.031 | Retinoic acid alpha receptor antagonist | 0.019 0.016 CID_154699984 | ||
| 0.044 | 0.019 | 0.044 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.033 | 0.008 | 0.037 | Retinoid X gamma receptor antagonist | 0.037 0.006 CID_154699984 | CID_154699984 | |
| 0.189 | 0.164 | 0.189 | 12-Lipoxygenase inhibitor | |||
| 0.047 | 0.022 | 0.047 | Liver X receptor alpha agonist | 0.038 0.033 CID_154699984 | ||
| 0.043 | 0.019 | 0.043 | Nicotinic acid receptor agonist | |||
| 0.062 | 0.038 | 0.062 | Biliverdin reductase inhibitor | 0.06 0.041 CID_154699984 | ||
| 0.062 | 0.039 | 0.062 | Beta tubulin antagonist | |||
| 0.123 | 0.1 | 0.123 | CC chemokine 6 receptor antagonist | |||
| 0.042 | 0.02 | 0.042 | Estrogen receptor alpha agonist | |||
| 0.096 | 0.075 | 0.107 | Adenylate kinase inhibitor | 0.107 0.057 CID_154699984 | CID_154699984 | |
| 0.138 | 0.118 | 0.18 | Amyloid beta aggregation inhibitor | 0.18 0.089 CID_154699984 | CID_154699984 | |
| 0.158 | 0.137 | 0.158 | Antiamyloidogenic | |||
| 0.047 | 0.026 | 0.049 | AICAR transformylase inhibitor | 0.049 0.024 CID_154699984 | CID_154699984 | |
| 0.071 | 0.052 | 0.081 | Glycine receptor agonist | 0.081 0.038 CID_154699984 | CID_154699984 | |
| 0.027 | 0.008 | 0.027 | Prostaglandin EP4 agonist | |||
| 0.036 | 0.017 | 0.036 | HCV NS5B polymerase inhibitor | |||
| 0.126 | 0.108 | 0.151 | Phospholipase A2 inhibitor | 0.151 0.073 CID_154699984 | CID_154699984 | |
| 0.033 | 0.015 | 0.033 | Endothelin receptor antagonist | |||
| 0.05 | 0.032 | 0.05 | Plasminogen activator inhibitor antagonist | |||
| 0.142 | 0.124 | 0.142 | Phospholipase C inhibitor | 0.138 0.132 CID_154699984 | ||
| 0.127 | 0.109 | 0.131 | Adenylate cyclase stimulant | 0.131 0.1 CID_154699984 | CID_154699984 | |
| 0.025 | 0.008 | 0.025 | Retinoic acid receptor antagonist | |||
| 0.097 | 0.081 | 0.097 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.02 | 0.004 | 0.02 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.049 | 0.033 | 0.049 | Dopamine beta hydroxylase inhibitor | |||
| 0.086 | 0.071 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.061 CID_154699984 | CID_154699984 | |
| 0.054 | 0.04 | 0.054 | Dihydroorotate oxidase inhibitor | |||
| 0.022 | 0.008 | 0.022 | Calcium-sensing receptor antagonist | |||
| 0.051 | 0.037 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.03 CID_154699984 | CID_154699984 | |
| 0.053 | 0.039 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.028 | 0.015 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.084 | 0.072 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.074 CID_154699984 | ||
| 0.028 | 0.016 | 0.028 | CXC chemokine 2 receptor antagonist | |||
| 0.085 | 0.073 | 0.085 | Glutamate release inhibitor | |||
| 0.123 | 0.113 | 0.123 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin D2 antagonist | |||
| 0.071 | 0.061 | 0.082 | GABA aminotransferase inhibitor | 0.082 0.044 CID_154699984 | CID_154699984 | |
| 0.062 | 0.052 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.193 | 0.184 | 0.193 | Vasodilator, peripheral | |||
| 0.151 | 0.142 | 0.151 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.032 | 0.025 | 0.032 | Liver X receptor beta agonist | |||
| 0.033 | 0.026 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Retinoic acid beta receptor antagonist | |||
| 0.067 | 0.061 | 0.067 | Glutamate dehydrogenase inhibitor | |||
| 0.048 | 0.041 | 0.048 | Factor III inhibitor | |||
| 0.066 | 0.06 | 0.071 | Aminopeptidase I inhibitor | 0.071 0.052 CID_154699984 | CID_154699984 | |
| 0.032 | 0.026 | 0.032 | Carboxypeptidase B inhibitor | 0.031 0.027 CID_154699984 | ||
| 0.193 | 0.188 | 0.197 | Vasodilator, coronary | 0.197 0.185 CID_154699984 | CID_154699984 | |
| 0.028 | 0.023 | 0.028 | Glucagon receptor antagonist | |||
| 0.083 | 0.078 | 0.083 | Uric acid excretion stimulant | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Progesterone antagonist | |||
| 0.009 | 0.005 | 0.009 | Free fatty acid receptor 2 antagonist | |||
| 0.012 | 0.008 | 0.012 | Retinoic acid receptor gamma antagonist | |||
| 0.032 | 0.029 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.029 CID_154699984 | ||
| 0.021 | 0.019 | 0.021 | Retinoic acid receptor agonist | |||
| 0.024 | 0.022 | 0.024 | Sodium/glucose cotransporter inhibitor | |||
| 0.087 | 0.084 | 0.087 | Anabolic | |||
| 0.093 | 0.09 | 0.112 | GABA C receptor antagonist | 0.112 0.061 CID_154699984 | CID_154699984 | |
| 0.022 | 0.021 | 0.022 | Prostaglandin H2 antagonist | |||
| 0.08 | 0.079 | 0.08 | Alcohol dehydrogenase inhibitor | |||
| 0.162 | 0.161 | 0.162 | Calpain inhibitor | |||
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.146 | 0.151 | 0.167 | Free radical scavenger | 0.167 0.127 CID_154699984 | CID_154699984 | |
| 0.021 | 0.027 | 0.024 | Lysine carboxypeptidase inhibitor | 0.024 0.022 CID_154699984 | CID_154699984 | |
| 0.021 | 0.035 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 CID_154699984 | CID_154699984 | |
| 0.027 | 0.043 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.029 CID_154699984 | CID_154699984 | |
| 0.051 | 0.068 | 0.062 | Nitric oxide donor | 0.062 0.045 CID_154699984 | CID_154699984 | |
| 0.073 | 0.09 | 0.082 | Aminopeptidase B inhibitor | 0.082 0.08 CID_154699984 | CID_154699984 | |
| 0.062 | 0.085 | 0.085 | Keratolytic | 0.085 0.043 CID_154699984 | CID_154699984 | |
| 0.071 | 0.097 | 0.09 | Prolactin inhibitor | 0.09 0.067 CID_154699984 | CID_154699984 | |
| 0.134 | 0.163 | 0.422 | Platelet antagonist | 0.422 0.023 CID_154699984 | CID_154699984 | |
| 0.055 | 0.086 | 0.067 | HIV-1 integrase inhibitor | 0.067 0.053 CID_154699984 | CID_154699984 | |
| 0.039 | 0.097 | 0.061 | Angiotensin-converting enzyme inhibitor | 0.061 0.028 CID_154699984 | CID_154699984 | |
| 0.07 | 0.132 | 0.142 | DNA polymerase I inhibitor | 0.142 0.054 CID_154699984 | CID_154699984 | |
| 0.114 | 0.188 | 0.384 | Platelet aggregation inhibitor | 0.384 0.02 CID_154699984 | CID_154699984 | |
| 0.027 | 0.113 | 0.081 | Elastase inhibitor | 0.081 0.016 CID_154699984 | CID_154699984 | |
| 0.026 | 0.119 | 0.173 | HIV-1 integrase (Strand Transfer) inhibitor | 0.173 0.011 CID_154699984 | CID_154699984 | |
| 0.03 | 0.139 | 0.145 | HIV-1 integrase (3'-Processing) inhibitor | 0.145 0.014 CID_154699984 | CID_154699984 | |
| 0.033 | 0.144 | 0.071 | Carbonic anhydrase XIII inhibitor | 0.071 0.057 CID_154699984 | CID_154699984 | |
| 0.088 | 0.205 | 0.484 | Platelet adhesion inhibitor | 0.484 0.005 CID_154699984 | CID_154699984 | |
| 0.055 | 0.217 | 0.1 | Carbonic anhydrase XV inhibitor | 0.1 0.066 CID_154699984 | CID_154699984 | |
| 0.055 | 0.233 | 0.117 | Hematopoietic | 0.117 0.023 CID_154699984 | CID_154699984 | |
| 0.084 | 0.324 | 0.85 | Thioredoxin glutathione reductase inhibitor | 0.85 0.004 CID_154699984 | CID_154699984 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |